Cite

Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option

Figure 1.

The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
eISSN:
2055-3390
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology